Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 41, 1620-1627, May 1, 1981]
© 1981 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Silinskas, K. C.
Right arrow Articles by McCormick, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Silinskas, K. C.
Right arrow Articles by McCormick, J. J.

Induction of Anchorage-independent Growth in Human Fibroblasts by Propane Sultone1

K. Charles Silinskas, Suzanne A. Kateley, John E. Tower, Veronica M. Maher and J. Justin McCormick2

Carcinogenesis Laboratory—Fee Hall, Departments of Microbiology and Biochemistry, Michigan State University, East Lansing, Michigan 48824

We have demonstrated a dose-dependent increase in the frequency of diploid human cells capable of anchorage-independent (AI) growth after treatment with the carcinogen propane sultone, followed by exponential growth to allow full expression of this phenotype (8 to 13 population doublings). Exposure to these same concentrations of propane sultone also resulted in a dose-dependent increase in the frequency of 6-thioguanine-resistant cells in the population. Procedures such as synchronization of cells and treatment just after the onset of DNA synthesis or the use of special selective medium were not essential for this induction. A very low frequency of cells with the AI phenotype was found in the control population (background). Cells which exhibited the AI phenotype spontaneously or after carcinogen treatment retained the characteristic over as many generations as tested (>13). The data suggest that AI growth is the result of a mutational event.

1 Supported in part by Department of Health and Human Services Grant CA 21289 from the National Cancer Institute and by a grant from the Elsa U. Pardee Foundation.

2 To whom requests for reprints should be addressed.

Received 9/15/80. Accepted 1/22/81.




This article has been cited by other articles:


Home page
ScienceHome page
R Holliday
The inheritance of epigenetic defects
Science, October 9, 1987; 238(4824): 163 - 170.
[Abstract] [PDF]


Home page
Toxicol Ind HealthHome page
C. Borek, A. Ong, and H. Mason
In Vitro Transformation of Human Cells by Radiation
Toxicology and Industrial Health, January 1, 1987; 3(3): 397 - 404.
[PDF]


Home page
ScienceHome page
J. Rhim, J Fujita, P Arnstein, and S. Aaronson
Neoplastic conversion of human keratinocytes by adenovirus 12-SV40 virus and chemical carcinogens
Science, April 18, 1986; 232(4748): 385 - 388.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1981 by the American Association for Cancer Research.